ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $52,600,000 | +62.0% | 565,956 | +3.8% | 0.01% | +57.1% |
| Q3 2021 | $32,476,000 | -18.3% | 545,357 | -6.5% | 0.01% | -22.2% |
| Q2 2021 | $39,758,000 | -3.9% | 582,965 | -2.3% | 0.01% | 0.0% |
| Q1 2021 | $41,393,000 | -30.4% | 596,527 | -22.9% | 0.01% | -35.7% |
| Q4 2020 | $59,444,000 | +1.9% | 773,709 | -0.8% | 0.01% | -12.5% |
| Q3 2020 | $58,359,000 | +7.9% | 780,307 | -9.2% | 0.02% | 0.0% |
| Q2 2020 | $54,105,000 | +55.3% | 859,499 | +3.6% | 0.02% | +33.3% |
| Q1 2020 | $34,850,000 | -23.2% | 829,772 | -17.0% | 0.01% | -7.7% |
| Q4 2019 | $45,393,000 | -0.8% | 999,407 | 0.0% | 0.01% | -7.1% |
| Q3 2019 | $45,743,000 | -11.7% | 999,407 | +13.1% | 0.01% | -12.5% |
| Q2 2019 | $51,827,000 | +70.1% | 883,963 | +30.1% | 0.02% | +60.0% |
| Q1 2019 | $30,465,000 | +42.5% | 679,550 | +23.8% | 0.01% | +25.0% |
| Q4 2018 | $21,374,000 | +180.8% | 548,744 | +231.7% | 0.01% | +300.0% |
| Q3 2018 | $7,613,000 | +185.1% | 165,421 | +144.7% | 0.00% | +100.0% |
| Q1 2018 | $2,670,000 | +16.3% | 67,591 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,296,000 | +33.2% | 67,591 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,724,000 | +51.2% | 67,591 | 0.0% | 0.00% | – |
| Q2 2017 | $1,140,000 | – | 67,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $100 | 0.00% |